methane has been researched along with Central Nervous System Diseases in 9 studies
Methane: The simplest saturated hydrocarbon. It is a colorless, flammable gas, slightly soluble in water. It is one of the chief constituents of natural gas and is formed in the decomposition of organic matter. (Grant & Hackh's Chemical Dictionary, 5th ed)
methane : A one-carbon compound in which the carbon is attached by single bonds to four hydrogen atoms. It is a colourless, odourless, non-toxic but flammable gas (b.p. -161degreeC).
Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Current treatments for cancer and the central nervous system diseases are limited, partly due to the difficulties posed by the insolubility, poor distribution of drugs among cells and lack of selectivity of drugs, the inability of drugs to cross cellular barriers and blood brain barrier (BBB)." | 2.55 | Carbon nanotubes-based drug delivery to cancer and brain. ( Guo, Q; Li, YY; Shen, XT; Xu, SQ, 2017) |
| "Functional gastrointestinal disorders (FGID) are defined by broad phenotypic descriptions and exclusion of recognizable disease." | 1.48 | Fermentable Sugar Ingestion, Gas Production, and Gastrointestinal and Central Nervous System Symptoms in Patients With Functional Disorders. ( Drewes, AM; Materna, A; Olesen, SS; Wilder-Smith, CH, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilder-Smith, CH | 1 |
| Olesen, SS | 1 |
| Materna, A | 1 |
| Drewes, AM | 1 |
| Anatovskaia, VS | 1 |
| Iashchenko, VI | 1 |
| Bruch, GE | 1 |
| Cordeiro, MF | 1 |
| Gomides, LS | 1 |
| Peixoto, C | 1 |
| Cordeiro, AP | 1 |
| Dal Bosco, L | 1 |
| Santos, AP | 1 |
| Barros, DM | 1 |
| Guo, Q | 1 |
| Shen, XT | 1 |
| Li, YY | 1 |
| Xu, SQ | 1 |
| Zhu, S | 1 |
| Huang, AG | 1 |
| Luo, F | 1 |
| Li, J | 2 |
| Zhu, L | 1 |
| Zhao, L | 1 |
| Zhu, B | 1 |
| Ling, F | 1 |
| Wang, GX | 1 |
| Zhang, Y | 1 |
| Bai, Y | 1 |
| Yan, B | 1 |
| Andrews, RJ | 1 |
| Nunes, A | 1 |
| Al-Jamal, K | 1 |
| Nakajima, T | 1 |
| Hariz, M | 1 |
| Kostarelos, K | 1 |
| Gilmore, JL | 1 |
| Yi, X | 1 |
| Quan, L | 1 |
| Kabanov, AV | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Fructose and Lactose Intolerance and Malabsorption: the Relationship Between Metabolism and Symptoms in Functional Gastrointestinal Disorders[NCT02085889] | 3,000 participants (Anticipated) | Observational | 2019-03-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for methane and Central Nervous System Diseases
| Article | Year |
|---|---|
Implications of PEGylation of Carbon Nanotubes for Central Nervous System Bioavailability.
Topics: Animals; Blood-Brain Barrier; Central Nervous System Diseases; Humans; Nanotechnology; Nanotubes, Ca | 2017 |
Carbon nanotubes-based drug delivery to cancer and brain.
Topics: Animals; Blood-Brain Barrier; Central Nervous System Diseases; Drug Delivery Systems; Humans; Nanotu | 2017 |
Functionalized carbon nanotubes for potential medicinal applications.
Topics: Animals; Central Nervous System Diseases; Communicable Diseases; Drug Carriers; Drug Delivery System | 2010 |
Application of carbon nanotubes in neurology: clinical perspectives and toxicological risks.
Topics: Animals; Central Nervous System; Central Nervous System Agents; Central Nervous System Diseases; Dru | 2012 |
Novel nanomaterials for clinical neuroscience.
Topics: Animals; Biopolymers; Blood-Brain Barrier; Central Nervous System Diseases; Coated Materials, Biocom | 2008 |
4 other studies available for methane and Central Nervous System Diseases
| Article | Year |
|---|---|
Fermentable Sugar Ingestion, Gas Production, and Gastrointestinal and Central Nervous System Symptoms in Patients With Functional Disorders.
Topics: Abdominal Pain; Administration, Oral; Adult; Breath Tests; Central Nervous System Diseases; Cluster | 2018 |
[On the clinical picture of methyl iodide lesions of the nervous system].
Topics: Central Nervous System Diseases; Female; Humans; Iodides; Methane | 1967 |
Application of Virus Targeting Nanocarrier Drug Delivery System in Virus-Induced Central Nervous System Disease Treatment.
Topics: Animals; Cell Line; Central Nervous System Diseases; Drug Carriers; Drug Delivery Systems; Larva; Na | 2019 |
Nanotechnology and drug delivery: Getting there is only half of the challenge! (Commentary).
Topics: Animals; Biomedical Research; Central Nervous System Diseases; Combined Modality Therapy; Deep Brain | 2012 |